Mitotic chromosome loss induced by methyl benzimidazole-2-yl-carbamate has been utilized as a rapid and simple method for assigning genes to individual chromosomes in Saccharomyces cerevisiae. This technique relied on the segregation of heterozygous markers in a diploid strain after methyl benzimidazole-2-ylcarbamate treatment due to loss of whole chromosomes. Correlations between the expression of an unmapped gene and that of a previously mapped recessive marker indicated chromosomal linkage. Depending on whether the unmapped gene and the marker were located in coupling or in repulsion, either positive or negative correlations were seen. The chromosomal location of several previously mapped genes were confirmed as a test of the method, and one previously unmapped gene, nibi, was mapped.
Although the genetic map of Saccharomyces cerevisiae has been extensively characterized, its long recombinational length (>4,600 centimorgans) and large number of chromosomes (16 or 17) (8) has often made assigning a new marker to a particular location on the linkage map tedious with conventional meiotic tetrad analysis. In this paper I report on the use of the highfrequency chromosome loss induced by the mitotic inhibitor methyl 2-yl-benzimidazole carbamate (MBC) as a simple and rapid method for localizing new markers to particular chromosomes in S. cerevisiae. This method requires only that the unmapped gene and recessive auxotrophic mutations marking the chromosomes be in a heterozygous state.
MATERIALS AND METHODS
Strains. The strains used, their genotypes, and their sources are listed in Table 1. Media. Minimal liquid medium contained, per liter, 1.6 g of yeast nitrogen base without amino acids or ammonium sulfate (Difco Laboratories), 10 g of succinic acid, 6 g of sodium hydroxide, 1 g of ammonium sulfate, and 20 g of dextrose. Amino acid, purine, or pyrimidine supplements were added at 4 ,ug/ml (except for adenine, which was added to a concentration of 8 ,ug/ml) as necessary for growth of particular strains. YEPD plates consisted of 1% yeast extract (Difco), 2% peptone (Difco), 40 ,ug of adenine per ml, 40 ,ug of uracil per ml, 2% dextrose, and 2% agar. Synthetic complete plates were similar to minimal liquid medium except that 4 pLg each of adenine, arginine, asparagine, cysteine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, serine, threonine, tryptophan, tyrosine, uracil, and valine per ml were added and the medium was solidified with 2% agar. Auxotrophic mutations were assayed on complete plates made without one or more supplements (complete -adenine, complete -arginine, etc.). The concentration of cycloheximide in the YEPD + cycloheximide plates was 10 SLg/ml.
Genetic techniques. Standard techniques of yeast genetic analysis (5) were used for constructing strains and complementation testing of markers. Mapping protocol. The mapping procedure utilized well-marked haploid strains which had auxotrophic mutations on 14 or 16 chromosomes ( Table 1) . One of these strains was mated to a strain containing the unmapped mutation of interest to produce a diploid heterozygous for both the auxotrophic markers and the unmapped gene. To make subsequent complementation tests easier, the diploid strains were X-ray treated and clones homozygous for mating type were isolated. This step was not essential since MATal MATa clones could be induced to sporulate and then the spores could be tested for complementation (G. Kawasaki The accuracy of this procedure for mapping different types of clones which could be observed after genes to particular chromosomes was tested MBC-induced chromosome loss for two heterozygous with two auxotrophic mutations whose chromorecessive mutations, depending on their linkage rela-somal locations have been previously estabtionship, are shown.
lished: ade6 and his4 ( Fig. 2 and 3 ). Both of these mutations were located in repulsion to the tation. MBC-induced loss of a chromosome in chromosomal markers used; hence, their linkage such a diploid cell would make it hemizygous for relationships were identified by negative correa recessive auxotrophic mutation on the homo-lations with particular chromosomal markers. A total of 255 MBC-treated clones of strain 6830 which had uncovered cyh2 were screened for the appearance of his4; 21 colonies were found. The percentage of colonies that had uncovered a particular chromosome marker and that were his4 was plotted as in the legend to Fig. 2 . Chromosome I did not carry a heterozygous marker, and therefore loss of this chromosome was not scored (dotted line). Since some, but not all, of the clones selected for resistance to cycloheximide (loss of chromosome VII) were his4, his4 must not be on chromosome VII; the actual level of correlation observed between the appearance of his4 and chromosome VII loss was not meaningful for chromosomal linkage (also shown as a dotted line). There were insufficient data for chromosome V (only one chromosome V loss colony found) to look for correlations between loss of chromosome V and appearance of his4 (dotted line). The very low frequency of his4 colonies which were also leu2 (the chromosome III marker) indicated that his4 was on chromosome III.
After MBC treatment of a heterozygous diploid, no colonies which were both ade6 and leul were seen, even though both were found separately many times. This result agrees with the known location of the ade6 and leul genes on chromosome VII (8) . his4 was verified to be on chromosome III in a similar manner: a strong negative correlation (<10%o) was observed with leu2 on chromosome III. The his4 auxotrophic colonies were screened for among cells which had been first selected for resistance to cycloheximide (uncovering the cyh2 allele). Although this preselection was done to facilitate scoring nib] in the same experiment (see below), it also reduced the number of MBC-treated colonies which needed to be screened for his4 (see Discussion).
A test of the method that used a positive correlation for markers in coupling was performed with argl. Occurrence of argi displayed a strong positive correlation with appearance of ade2 (>90%o), the chromosome XV marker (Fig.  4) . Both of these auxotrophic mutations have been mapped to chromosome XV (8) .
Strain NH429-6A was originally thought to carry Iys9 on chromosome XIV and met2 on chromosome XVII. However, the very strong positive correlation seen between lys9, the chromosome XIV marker, and met2 (>95%; Fig. 5 ) suggested that these genes were both on the same chromosome. This has now been confirmed; markers previously identified as being on chromosome XVII are now known to be located on the left arm of chromosome XIV (S. Klapholtz and R. Esposito, submitted for publication).
From these results, I concluded that a positive or negative correlation for the joint appearance of recessive markers after MBC treatment indicated chromosomal linkage for the markers.
MBC-induced chromosome loss was used to (Fig. 6 ), indicating that nib) was probably located on chromosome XVI. Meiotic mapping subsequently confirmed this; nib) was found to be tightly linked to radl on the left arm of chromosome XVI (1) . markers after MBC treatment of a diploid strain initially heterozygous for these markers. The correlations observed were not absolute for several reasons. Aneuploid clones frequently grew slowly, making some of the auxotrophic markers difficult to score. Occasional mitotic recombination events changed the linkage relationships of the unmapped gene and the chromosomal markers. Finally, although the average frequency of loss for each chromosome was equal, random fluctuations about this average sometimes yielded an insufficient number of observations for particular chromosomes. Nevertheless, the observed correlations limited a gene to one or, at most, a few chromosomes, greatly reducing the amount of work needed to map it accurately with conventional tetrad analysis. Empirically, for a mutation located in repulsion to the chromosomal markers, between 25 and 75 colonies showing the phenotype of the unmapped mutation were sufficient to obtain a negative correlation (<10%o joint appearance of the unmapped mutation and a chromosomal marker) and assign CHROMOSOME FIG. 4 . Mapping argi. A total of 2,500 MBC-treated clones of strain 6808 were screened for the appearance of argl and recessive chromosome marker auxotrophies; 108 argi colonies were found. The percentage of colonies that had uncovered a particular chromosome marker and which were argi was plotted as in the legend to Fig. 2 . Chromosomes I and XIII did not carry heterozygous markers, and therefore loss of either of these chromosomes was not scored (dotted lines). The very high frequency of argi colonies which were also ade2 (the chromosome XV marker) indicated that argl was on chromosome XV. A total of 2,500 MBC-treated clones of strain 6808 were screened for the appearance of met2 and recessive chromosome marker auxotrophies; 92 met2 colonies were found. The percentage of colonies that had uncovered a particular chromosome marker and that were met2 was plotted as in the legend to Fig. 2 . Chromosomes I and XIII did not carry heterozygous markers, and therefore loss of either of these chromosomes was not scored (dotted lines). The very high frequency of met2 colonies that were also Iys9 (the chromosome XIV marker) indicated that met2 was on chromosome XIV. the gene to a linkage group. For a mutation located in coupling to the chromosomal markers, fewer clones were required to detect a positive correlation (>90%) between an unmapped mutation and a chromosome marker. Since multiple loss events within a single cell occur more frequently than expected on the basis of independence (although which chromosomes are lost is random) (12), it was not possible to make any statistical calculation of the minimum number of clones necessary to obtain an unambiguous chromosome assignment.
DISCUSSION
Nonindependence of chromosome loss within a single cell also reduced the total number of colonies that had to be screened for the unmapped phenotype from the total required if events were independent. By using a drug resistance marker to first select cells that had already undergone at least one chromosome loss, the frequency of cells that had lost multiple chromosomes was increased. This result greatly increased the frequency of cells in which the unmapped gene and the chromosomal markers were uncovered. The total number of colonies screened for his4 or nib), which were first selected for loss of chromosome VII (uncovering cyh2), was 10-fold less than the number screened for the mapping of other genes, where a preselection for loss of one chromosome was not carried out (ade6, argl, and met2 in Fig. 2,  4, and 5) .
A dominant mutation could be mapped with this technique in the same manner as a recessive mutation, except that one would look for a correlation between the loss of the dominant phenotype and uncovering of a recessive auxotrophy, mapping the location of the recessive, wild-type allele of the gene rather than the dominant, mutant allele.
Chromosome nondisjunction or loss, both spontaneous and induced, have been previously used as mapping tools in a number of organisms: a number of workers have used the chromosome instability of human-mouse hybrid cell lines to locate a large number of human genes (4, 9) . In both Aspergillus and Schizosaccharomyces, A total of 255 MBC-treated clones of strain 6830 that had uncovered cyh2 were screened for the appearance of nib) and recessive chromosome marker auxotrophies; 24 nib) colonies were found. The percentage of colonies that had uncovered a particular chromosome marker and that were nib) was plotted as in the legend to Fig. 2 . Chromosome I did not carry a heterozygous marker, and therefore loss of this chromosome was not scored (dotted line). Since some, but not all, of the clones selected for resistance to cycloheximide (loss of chromosome VII) were nib), nib) must not be on chromosome VII; the actual level of correlation observed between the appearance of nib) and chromosome VII loss was not meaningful for chromosomal linkage (also shown as a dotted line). There were insufficient data for chromosome V (only one chromosome V loss colony found) to look for correlations between loss of chromosome V and appearance of nib) (dotted line). The very low frequency of nib) colonies which were also aro7 (the chromosome XVI marker) indicated that nib) was on chromosome XVI. used extensively to assign mutations to linkage groups (2, 3). cdc6 (Kawasaki, Ph.D. thesis, 1979) and rad52 (D. Schild, personal communication) have been used in Saccharomyces to induce chromosome loss for mapping genes. A number of other methods for mapping genes in Saccharomyces that rely on mitotic recombination (7), triploid segregation patterns (11) , disome analysis (6), or abolition of meiotic recombination (Klapholtz and Esposito, submitted for publication) have also been developed. These techniques have facilitated mapping new markers; however, most still require some tetrad analysis, or crossing the marker to be mapped into a particular genetic background. Unlike these methods, mapping with MBC does not rely on a homozygous mutation to cause chromosome loss and does not require extensive strain construction. Genes can be mapped in any genetic background; no crosses or dissections are necessary other than making a heterozygous diploid with one of the multiply marked strains available (Yeast Genetic Stock Center, Berkeley, Calif). Furthermore, the high frequency of multiple-loss events greatly reduces the amount of work necessary to map a mutation with a nonselectable phenotype.
